 CAMBRIDGE, Mass.--BUSINESS WIRE--Epizyme, Nasdaq: EPZM, a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced that it will host a call to discuss the Companys strategic vision on Tuesday, March 2, 2021 at 10:00 a.m. ET. The Next EPIsode: Rewriting Oncology Treatment with Epigenetics Date: Tuesday, March 2, 2021 Time: 10:00 11:30 a.m. ET Program: Epizyme 2021 and Beyond The Role of Epigenetics in Oncology Tazve 